Jack Chia Industries (Thailand) Public Company Limited

JCT.BK

Medical - Pharmaceuticals · Healthcare

Price

84.50 THB

+0.00 (+0.00%)

Market Cap

1.14B THB

Exchange

Stock Exchange of Thailand

Winston Score

Winston is curious

A decent business — some strong pillars, some weaker.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Good

Growth

Good

Cash Flow

Good

Stability

Good

Valuation

Good

Dividends

Exceptional

Track this stock — start free trial

Winston Score History

The full picture

Jack Chia Industries (Thailand) is a Thai healthcare company that makes and sells pharmaceutical products, consumer health goods, and medical supplies. Its products include medicines, vitamins, and health supplements sold to hospitals, pharmacies, and everyday consumers across Thailand. The company is one of the established local pharmaceutical manufacturers in the Thai market.

The company earns money by selling its products directly to retailers, distributors, and healthcare institutions. It operates primarily in Thailand, with a market capitalization of around $1.1 billion, and its competitive position rests on its local brand recognition, established distribution network, and manufacturing capabilities built over decades. A key growth driver is Thailand's aging population, which is expected to increase demand for medicines and health products over time, though the company faces ongoing risk from competition by larger multinational pharmaceutical firms and potential pressure on drug pricing from government healthcare policies.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+5.3% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+7.4% YoY

YoY Growth Rate

Slow EPS growth

R&D Spend

0 THB/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

78.9%ownership

Insiders own a meaningful stake in the company

Cash Position

Cash flow positive

603M THB cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Jack Chia Industries (Thailand) Public Company Limited is growing revenue at 5% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 13.5M (2021) → 13.5M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

45.5%

Healthy — 45.5% gross margin

Profit after running costs

Operating Margin

14.5%

Healthy — 14.5% operating margin

Return on the money invested

ROCE

8.6%

Below par — 8.6% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+6.3%

Slow sales growth (+6.3% YoY)

Profit growth

EPS YoY

+20.8%

Earnings growing fast (+20.8% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is

EPS Consistency

6/8 quarters

Earnings grew in most of the last 8 quarters

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

86%

Modest — 86% of profit becomes cash

Spare cash per sale

FCF Margin

9.6%

Modest free cash flow (9.6%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

N/A

Data not available

Covers its interest

Interest Cover

175.09x

Comfortably covers interest (175.1x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

9.1x

Attractive valuation — P/E 9.1

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

5.87%

Healthy income — 5.87% yield

Generous yield. Worth checking whether the payout is sustainable.

Dividend record

Dividend Growth

+14.0%

Dividend growing fast (14.0% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial